Database
User
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MEMBRANE POTENTIAL | 25.60±4.41 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 30.83 | human | HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 20.73±14.69 | rat | hepatocytes | MMP assay | decrease | IC50 | 163 | |
| (4-chlorophenyl)-(4-pyridin-4-ylmethyl-phthalazin-1-yl)amine | (4-chlorophenyl)-[4-(4-pyridylmethyl)phthalazin-1-yl]amine | (A) PTK787 |
| 1 -(4-Chloroanilino)-4-(4-pyridylmethyl)phthalazine | 1-(4-Chloranilino)-4-(4-pyridylmethyl)-phthalazin | 1-(4-chlor-anilino)-4-(pyridin-4-yl-methyl)-phthalazine |
| 1-(4-chloranilino)-4-(4-pyridylmethyl)-phthalazine | 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine | 1-Phtalazinamine, N-(4-chlorophenyl)-4-(4-pyridinylmethyl)- |
| 1-Phthalazinamine, N-(4-chlorophenyl)-4-(4-pyridinylmethyl)- | 1-Phthalazinamine,N-(4-chlorophenyl)-4-(4-pyridinylmethyl)- | 139368-EP2270008A1 |
| 139368-EP2292617A1 | 141V543 | 212141-54-3 |
| 5DX9U76296 | A1778 | A815203 |
| AB0019678 | AB01275455-01 | AB1004881 |
| AC-25025 | ACT06794 | AKOS015896483 |
| API0004576 | AS-17435 | BAY-86-5127 |
| BCP16436 | BCPP000021 | BDBM4851 |
| BIFK0006 | BRD-K70163715-001-02-8 | C20H15ClN4 |
| CAS-212141-54-3 | CCG-220471 | CGP 79787 |
| CGP-7978 | CGP-79787 | CGP-797870 |
| CGP79787 | CHEBI:90620 | CHEMBL101253 |
| CS-5248 | CTK4E6114 | D06285 |
| DB-066452 | DB04879 | DSSTox_CID_26919 |
| DSSTox_GSID_46919 | DSSTox_RID_82015 | DTXSID2046919 |
| EX-A1398 | F9995-0196 | FT-0657115 |
| GTPL5705 | HMS2089D11 | HMS3713O04 |
| HMS3745G07 | HY-10203 | K-222584 |
| Kinome_3657 | LS-187006 | LS-187641 |
| MCULE-3078477385 | N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine | N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)-1-phthalazinamine |
| N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phtalazin-1-amine | N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine | N-(p-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine; |
| NCGC00181350-01 | NCGC00181350-03 | NCGC00181350-06 |
| NVP-PTK787 | PTK-787 | PTK/ZK |
| PTK787 | Pynasunate | Q7917084 |
| QCR-126 | RT-016221 | SB16582 |
| SCHEMBL18286 | SR-05000001457 | SR-05000001457-1 |
| SR-05000001457-2 | Tox21 112808 | Tox21_112808 |
| Tox21_112808_1 | UNII-5DX9U76296 | VU0549317-1 |
| Vatalanib | Vatalanib (USAN/INN) | Vatalanib (free base) |
| Vatalanib [USAN:INN] | Vatalanib base | Vatalanib free base |
| Vatalinib | YCOYDOIWSSHVCK-UHFFFAOYSA-N | ZINC7460 |
| ZK-222584 | ZK-232934 | ZK222584 |
| ZX-AFC002994 | cid_151194 |